- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03217227
Evaluating Myocardial Ischemia in Chest Pain Using Exercise CMR (EMPIRE)
Evaluating Myocardial Ischemia in Chest Pain Using Cardiovascular Magnetic Resonance (CMR) Imaging Exercise Bike
Ischemic Heart Disease (IHD) is a condition of recurring chest pain or discomfort that occurs when a part of the heart is not receiving sufficient blood flow. It is a major public health concern internationally and in Singapore, the leading cause of death from cardiovascular disease. Cardiovascular magnetic resonance (CMR) has the ability to assess heart structures, scarring or lack of blood supply to the heart muscle with great accuracy and without any radiation involved. A CMR-compatible cycle ergometer can offer a safe and low cost stress equipment to assess heart function and motion abnormalities, and restrictions of the blood supply to the heart tissues due to partial or complete blockages of the blood vessels.
This study aims
- to develop an exercise-CMR stress protocol by testing its feasibility and robustness in assessing changes in cardiac volumes and function due to physical exertion in healthy individuals and
- to assess the accuracy of the multiparametric stress-CMR as a diagnostic tool for ischemic-causing coronary artery disease (CAD) with coronary fractional flow reserve (FFR) as a reference.
- to measure the overall economic impact of ischaemic heart disease by estimating the direct and indirect medical costs for each participant. The current sample costs will be extrapolated to estimate the annual costs of treating and managing ischaemic heart disease in the local population.
- to evaluate the effects of coronary microvascular dysfunction on coronary flow and regulation, physiological response and cardiac sympathetic signaling in patients with chest pain.
Study Overview
Status
Conditions
Detailed Description
Suspected ischemic heart disease (IHD) or coronary artery disease (CAD) is commonly diagnosed by stress testing where patients undergo exercise tests in order to make their hearts work hard and beat fast to require more blood and oxygen. Pharmacological-induced stress is employed in the case where the patient is unable to exercise. Since plaque-narrowed arteries cannot supply enough oxygen-rich blood to meet the heart's needs, the stress test can show signs and symptoms of IHD. Some of the symptoms include abnormal changes in the heart rate or blood pressure, shortness of breath, chest pain, or abnormal changes in the heart's rhythm and electrical activity.
As part of the stress tests, images of the heart are taken while the patient is exercising and while the patient is at rest. The imaging stress tests will show how well the blood flows in and out of the heart. An example would be a stress echocardiogram where an ultrasound is performed on the chest to produce video images of the heart to. IHD is detected through development of new regional wall motion abnormalities or worsening of preexisting regional wall motions. The patient will be required to exercise on a treadmill before lying on the examination bed for the ultrasound scan. This however, would require the patient to move from the treadmill to the bed, which would result in some time delay.
Another diagnostic test commonly used to diagnose IHD would be a nuclear scan known as myocardial perfusion imaging where a radioactive isotope acting as a tracer is injected into the bloodstream. During exercise, the tracer is monitored while it flows through the heart and lungs to allow detection for any blood-flow problems. However, this test would involve ionizing radiation due to the radioactive isotopic tracer used.
A detailed test to view blood flow through the heart, would be through a cardiac catheterization or an angiogram where a thin and flexible tube known as a catheter is threaded through an artery, usually in the leg, to the heart arteries. An invisible dye is injected through the catheter and special x-rays will be taken while the dye flows through the coronary arteries, allowing the doctor to study the blood flow through the heart and blood vessels. Due to the nature of the catheterization with the insertion of the tube, it makes the procedure invasive and hence involving risks although they are rare.
Cardiovascular magnetic resonance (CMR) is able to accurately and non-radiatively assess the heart structure, any scarring or lack of blood supply to the heart muscle. A CMR-compatible cycle ergometer offers a one-stop diagnostic test that is non-radiative and non-invasive. Hence, our investigators aim to develop a protocol that does not require any invasive procedure by assessing its accuracy and develop reference ranges in healthy individuals.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Thu Thao Le, PhD
- Phone Number: 67042241
- Email: le.thu.thao@nhcs.com.sg
Study Contact Backup
- Name: Sheryl Lieo, B Sc.
- Phone Number: 67042305
- Email: sheryl.lieo.w.x@nhcs.com.sg
Study Locations
-
-
-
Singapore, Singapore, 169609
- Recruiting
- National Heart Centre Singapore
-
Contact:
- Le Thu Thao, PhD
- Phone Number: 6704 2241
- Email: le.thu.thao@nhcs.com.sg
-
Principal Investigator:
- Thu Thao Le, PhD
-
Sub-Investigator:
- Calvin Chin, MBBS, PhD
-
Contact:
- Sheryl Lieo, BSc
- Phone Number: 6704 2305
- Email: sheryl.lieo.w.x@nhcs.com.sg
-
Singapore, Singapore
- Recruiting
- National Heart Centre Singapore
-
Contact:
- Thu Thao Le, PhD
- Phone Number: 67042241
- Email: le.thu.thao@nhcs.com.sg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
The major source of recruitment for healthy volunteers will be from an existing database of healthy volunteers who have participated in the biobank program and have indicated interest in future studies. Other sources include co-workers of the department who volunteer and indicate on the Informed Consent Document that their participation was entirely voluntary and not coerced. Study Team members are ineligible.
The major source of recruitment for patients with stable angina will be from the imaging and admission databases of the National Heart Centre Singapore. Patients are also referred by their attending healthcare professionals. The primary physicians of the patients identified will be notified and recruitment will only proceed if the primary physician is agreeable.
Description
Inclusion Criteria:
Healthy Volunteers:
- 21 years and above
- Normal physical examination
- No known significant medical history
- Able to give informed consent
Patients:
- 21 years and above
- Stable angina or angina-equivalent
Has at least one of the following risk factors:
- Smoking
- Diabetes (fasting glucose level > 140 mg/dL)
- Hyperlipidemia (total cholesterol level > 250 mg/dL)
- Abnormal ECG
- Hypertension
Exclusion Criteria:
Healthy Volunteers:
- Contraindications to CMR implantable devices, cerebral aneurysm clips, cochlear implants
- Claustrophobia
- Women who are pregnant
- Inability to comply with study protocol
- Not able to exercise
Patients:
- Unstable cardiac conditions that are deemed by primary investigator to be unsuitable for this study
- Prior coronary revascularization or percutaneous coronary intervention
- Pulmonary disease
- Anemia
- Asthma
- Hyperthermia
- Hyperthyroidism
- Sympathomimetic toxicity
- Polycythemia
- Severely uncontrolled hypertension despite being on at least 3 anti-hypertensive medications
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Healthy Volunteer
Healthy Volunteers will undergo the following study procedures:
|
A rest scan is performed and a gadolinium contrast may be administered during the scan (depending on the kidney function).
After the rest scan is completed, images of the subject's heart during exercise via cycling in the supine position, will be scanned.
Other Names:
|
Patients with Stable Angina
Patients will undergo the following study procedures:
|
A rest scan is performed and a gadolinium contrast may be administered during the scan (depending on the kidney function).
After the rest scan is completed, images of the subject's heart during exercise via cycling in the supine position, will be scanned.
Other Names:
It is a procedure to diagnose and treat cardiovascular diseases by inserting a long and thin tube known as a catheter into the artery or vein in the neck, groin or arm and threaded through the blood vessels to the heart. A coronary angiogram is also performed during the procedure where an invisible contrast dye (only visible in the X-rays) is injected through the catheter and X-ray images scanned will show the flow of the dye through the heart arteries to determine any blockages in the arteries. In the case where there is severe narrowings, fractional flow reserve (FFR) may be performed to measure the pressure in the coronary arteries. If there is no significant narrowing lesions, the interventionist may perform additional flow resistance measurements of the small vessels to further investigate the cause of angina
Other Names:
The test studies the structure and function of the eye vessels.
It involves using eye drops to dilate the pupils, allowing the retinal photographer to have a better view of the back of the eye.
The test studies the cardiac sympathetic signalling that may help to identify patients with high risks of adverse events. The scan consists of 2 acquisitions of images 3-4 hours apart. For this study, only patients without clinically significant lesions (diagnosed via the cardiac catetherisation and have normal FFR results) will undergo this test.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
First occurrence of cardiovascular event
Time Frame: One year
|
The outcomes are obtained via hospital records or phone follow-ups
|
One year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Le Thu Thao, PhD, National Heart Research Institute Singapore
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Vascular Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Pain
- Neurologic Manifestations
- Heart Diseases
- Coronary Artery Disease
- Myocardial Ischemia
- Coronary Disease
- Cardiovascular Diseases
- Ischemia
- Chest Pain
- Molecular Mechanisms of Pharmacological Action
- Enzyme Inhibitors
- Antineoplastic Agents
- Radiopharmaceuticals
- 3-Iodobenzylguanidine
Other Study ID Numbers
- 2017/2123
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myocardial Ischemia
-
Recardio, Inc.CompletedAcute Myocardial Infarction | STEMI - ST Elevation Myocardial Infarction | Acute Myocardial IschemiaNetherlands, Hungary, Austria, Poland, Belgium
-
University of Roma La SapienzaCompletedRosuvastatin in Preventing Myonecrosis in Elective Percutaneous Coronary Interventions (PCIs) (ROMA)Periprocedural Myocardial NecrosisItaly
-
Lokien van NunenMaquet Cardiovascular; Stichting Toegepaste Wetenschappen (project number 11052)CompletedAcute Myocardial Infarction | Persisting Ischemia | No ReflowNetherlands
-
University Hospital "Sestre Milosrdnice"CompletedSTEMI - ST Elevation Myocardial Infarction | Myocardial ReperfusionCroatia
-
Tomsk National Research Medical Center of the Russian...CompletedMyocardial Infarction | Myocardial Injury | STEMI | Myocardial NecrosisRussian Federation
-
Fundacio Privada Mon Clinic BarcelonaMiracor Medical SANot yet recruiting
-
University Hospital, ToulouseThoratec CorporationWithdrawnChronic Myocardial IschemiaFrance
-
Deutsches Herzzentrum MuenchenCompletedInfarction, MyocardialGermany
-
Barts & The London NHS TrustUniversity College, London; Queen Mary University of LondonCompletedAcute Myocardial InfarctionSwitzerland, Denmark, United Kingdom
-
Tehran University of Medical SciencesRecruitingMyocardial Infarction | Myocardial Ischemia | Myocardial StunningIran, Islamic Republic of
Clinical Trials on Cardiovascular Magnetic Resonance Imaging with Exercise Bike
-
University of LeicesterUniversity Hospitals, LeicesterCompleted
-
Boston Children's HospitalCompleted
-
Medical University InnsbruckRecruitingAcute ST-Elevation Myocardial InfarctionAustria
-
Society for Cardiovascular Magnetic ResonanceUnknownCardiovascular Diseases
-
Groupe Hospitalier Paris Saint JosephActive, not recruitingAortic RegurgitationFrance
-
Cardiovascular Research Institute DublinActive, not recruitingCovid19 | Cardiomyopathies | SARS-CoV InfectionIreland
-
National Heart Centre SingaporeCompletedPulmonary HypertensionSingapore
-
University of Wisconsin, MadisonNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...CompletedPulmonary Arterial Hypertension (PAH)
-
Maastricht University Medical CenterDutch Heart FoundationCompletedMyocardial Infarction | Myocardial Ischemia | Coronary Artery Disease | Chest Pain | Acute Coronary SyndromeNetherlands
-
Columbia UniversityGE HealthcareCompletedCovid19 | Myocarditis | Cardiac Arrhythmia | Cardiac Disease | Left Ventricular DysfunctionUnited States